Science & Precision Medicine
Molecular oncology, biomarkers and precision medicine, combining molecular biology, bioinformatics and computational approaches.
Scientist · Innovator · Public Policy Leader
Geraldine Gueron works at the intersection of research, biotechnology, entrepreneurship and innovation — connecting the laboratory, technology, startups, institutions and government.

ONE QUESTION
Science creates knowledge. Entrepreneurs turn ideas into solutions. Investment provides scale. Institutions create the conditions for innovation to happen. My career has increasingly developed at the intersection of those worlds.
Molecular oncology, biomarkers and precision medicine, combining molecular biology, bioinformatics and computational approaches.
Turning scientific discoveries into technologies, solutions and ventures capable of creating impact.
Connecting researchers, universities, entrepreneurs, investors, corporations and government.
Approaching science and technology as strategic capabilities for development and competitiveness.

SCIENCE BEYOND THE LAB
Scientific discoveries create their greatest value when they can travel.
From research and data to biotech ventures and public policy, Geraldine's work is driven by a practical question: what does it take to move knowledge from discovery to adoption?
Read more →SPEAKING & ADVISORY
How discoveries move from laboratories into ventures, solutions and public value.
What ecosystems need to transform scientific capabilities into innovation and growth.
How biology and computation are reshaping biomedical research and healthcare.
CURRENT WORK
Leading research in molecular oncology, biomarkers and precision medicine at UBA-CONICET.
Building PreGen and translating scientific knowledge into molecular diagnostic solutions.
Leading Science and Technology for the City of Buenos Aires and strengthening its deep tech ecosystem.

Entrepreneurship adds a third vantage point to a career spanning research and public policy.
For speaking, advisory, international collaboration and initiatives across science, biotech, deep tech and innovation.
Let's connect